Longevity Medicine becomes more accessible to everyone thanks to Cerba HealthCare Italia.
Available in over 400 medical centers across Italy, it requires an investment between €300 and €800: one-tenth of the cost of programs offered across Europe.
While longevity medicine is filling newspaper columns, lighting up cultured gatherings, and starting to attract VIPs through niche services reserved for a few privileged individuals, Cerba HealthCare Italia, a leader in diagnostics and healthcare prevention, is introducing a new accessible and innovative longevity pathway. Available in over 400 medical centers throughout Italy, it leverages advanced 3.0 medicine technologies to improve health and prolong life in a healthy way.
Medicine 3.0, as defined by the most expert international scholars (including several Italian excellencies), no longer focuses solely on curing diseases but instead emphasizes prevention and health optimization. This is achieved through cutting-edge technologies such as artificial intelligence, genomics, and advanced data analysis. This approach allows for personalized treatments, preventing the onset of diseases, and improving the individual’s overall well-being. Cerba HealthCare Italia has integrated these technologies into its Longevity pathways, making them available to anyone who wants to proactively care for their health.
Once a topic of interest only to a select elite, longevity pathways have often been characterized by high costs (ranging between €3,000 and €8,000 per person per year) and limited accessibility. These are challenging figures, embedded in a cultural legacy where only a few individuals have the awareness to invest in their health, assuming they have the financial capability. Cerba HealthCare Italia has created a service that not only maintains high-quality standards but is also economically accessible. The goal is to bridge both economic and cultural gaps.
It’s worth noting that Cerba HealthCare Italia owns cutting-edge laboratories that perform tests for many healthcare providers, including those most committed to longevity. ‘We are happy to see how interest in longevity is growing and how more and more centers are relying on our excellence for analysis and biomarker measurement,’ says Stefano Massaro, CEO of Cerba HealthCare Italia. ‘Our goal is to make this pathway available to all individuals who genuinely want to improve their health and extend their healthy lifespan through an investment of between €300 and €800, one-tenth of the cost of comparable programs across Europe, without even considering the enormous costs in the United States.’
Cerba HealthCare Italia’s Longevity service is based on an in-depth health profile analysis, including an extensive initial list of specific blood tests to measure biomarkers that can be individually addressed. Advanced diagnostic tests (available in select locations) can be performed to analyze visceral fat and VO2max, and through telemedicine services, patients can receive personalized advice—based on biomarkers—to improve their lifestyle. The proposal includes targeted strategies for nutrition, physical activity, and sleep management, which can be easily monitored through wearable devices. ‘It is essential for many individuals to be educated and supported in using wearable devices,’ adds Stefano Massaro.
‘We are aware, and we want our patients to be increasingly aware, that longevity does not only depend on genetics but on conscious and modifiable lifestyle choices,’ Massaro emphasizes. ‘Our service has been designed to be not only effective but also accessible, offering anyone the opportunity to take care of their health in a scientific and sustainable way. Of course, the condition is that the individual must be motivated by an emotional investment much more than a financial one, to undertake an important journey that can change their life.’
With the launch of the Longevity service, Cerba HealthCare Italia demonstrates that advanced medicine can be within everyone’s reach, providing a personalized pathway to improve the quality of life and prevent diseases. ‘This is the future of healthcare, and we are proud to make it accessible to everyone,’ concludes Massaro, ‘while we await that individual choices will one day guide public health spending towards this type of service—though perhaps it’s still early for that. But it will happen!’
For more information, visit the website: www.cerbahealthcare.it, where an entire section is dedicated to Longevity services.